Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.
Scope of the Report:
Transcranial Magnetic Stimulators (TMS) is widely sales for Depression, Tinnitus, Alzheimer, Parkinson's Disease, Psychiatric Disorders, Headache, Stroke, etc. The most proportion of Transcranial Magnetic Stimulators (TMS) is used for Depression, and the consumption proportion is about 20% in 2017.
Europe is the largest supplier of Transcranial Magnetic Stimulators (TMS), with a production market share 38.5%. The second place is North America, following Europe with the production market share of 32%.
North America is the largest consumption place, with a consumption market share nearly 32.3% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.9%, China is also an important sales region for the Transcranial Magnetic Stimulators (TMS).
The worldwide market for Transcranial Magnetic Stimulators (TMS) is expected to grow at a CAGR of roughly 10.4% over the next five years, will reach 130 million US$ in 2024, from 71 million US$ in 2019, according to a new WMR study.
This report focuses on the Transcranial Magnetic Stimulators (TMS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Dr. Langer Medical
MAG & More
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transcranial Magnetic Stimulators (TMS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transcranial Magnetic Stimulators (TMS), with price, sales, revenue and global market share of Transcranial Magnetic Stimulators (TMS) in 2017 and 2018.
Chapter 3, the Transcranial Magnetic Stimulators (TMS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transcranial Magnetic Stimulators (TMS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transcranial Magnetic Stimulators (TMS) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transcranial Magnetic Stimulators (TMS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.